Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Lix

Showing results (331-340 of 396) with videos related to

Pageof 40
Sort By:
Diabetes, Obesity & Metabolism|May 9, 2020
Sodium-glucose co-transporter-2 inhibitors and the risk of urosepsis: A multi-site, prevalent new-user cohort studyAnat Fisher, Michael Fralick, Kristian B Filion, et al.
Archives of Public Health = Archives Belges De Sante Publique|March 26, 2026
Impact of risk mitigation measures on oral fluoroquinolone prescribing: a multi-site population-based Canadian cohort studyLisa M Lix, Matthew Dahl, Audray St-Jean, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 13, 2023
Response shift results of quantitative research using patient-reported outcome measures: a descriptive systematic reviewRichard Sawatzky, Tolulope T Sajobi, Lara Russell, et al.
Inflammatory Bowel Diseases|December 4, 2020
The Impact of Psychiatric Comorbidity on Health Care Utilization in Inflammatory Bowel Disease: A Population-based StudyCharles N Bernstein, Carol A Hitchon, Randy Walld, et al.
AIDS (London, England)|November 20, 2025
Antiretroviral utilization and adherence before versus after expansion of a provincial drug insurance policyAnn M Babu, Donica Janzen, Charity D Evans, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 21, 2023
Unsupervised item response theory models for assessing sample heterogeneity in patient-reported outcomes measuresTolulope T Sajobi, Ridwan A Sanusi, Nancy E Mayo, et al.
Journal of Psychosomatic Research|June 18, 2023
Assessment of differential item functioning of the PHQ-9, HADS-D and PROMIS-depression scales in persons with and without multiple sclerosisRuth Ann Marrie, Lisa M Lix, James M Bolton, et al.
BMC Research Notes|November 28, 2017
Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative dataRuth Ann Marrie, Randy Walld, James M Bolton, et al.
Arthritis Care & Research|June 15, 2019
Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid ArthritisCarol A Hitchon, Lixia Zhang, Christine A Peschken, et al.
Inflammatory Bowel Diseases|September 3, 2024
Psychiatric Comorbidity Does Not Enhance Prescription Opioid Use in Inflammatory Bowel Disease as It Does in the General PopulationCharles N Bernstein, John D Fisk, Randy Walld, et al.
Pageof 40

Showing results (331-340 of 396) with videos related to

Sort By:
Pageof 40
Diabetes, Obesity & Metabolism|May 9, 2020
Sodium-glucose co-transporter-2 inhibitors and the risk of urosepsis: A multi-site, prevalent new-user cohort studyAnat Fisher, Michael Fralick, Kristian B Filion, et al.
Archives of Public Health = Archives Belges De Sante Publique|March 26, 2026
Impact of risk mitigation measures on oral fluoroquinolone prescribing: a multi-site population-based Canadian cohort studyLisa M Lix, Matthew Dahl, Audray St-Jean, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 13, 2023
Response shift results of quantitative research using patient-reported outcome measures: a descriptive systematic reviewRichard Sawatzky, Tolulope T Sajobi, Lara Russell, et al.
Inflammatory Bowel Diseases|December 4, 2020
The Impact of Psychiatric Comorbidity on Health Care Utilization in Inflammatory Bowel Disease: A Population-based StudyCharles N Bernstein, Carol A Hitchon, Randy Walld, et al.
AIDS (London, England)|November 20, 2025
Antiretroviral utilization and adherence before versus after expansion of a provincial drug insurance policyAnn M Babu, Donica Janzen, Charity D Evans, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 21, 2023
Unsupervised item response theory models for assessing sample heterogeneity in patient-reported outcomes measuresTolulope T Sajobi, Ridwan A Sanusi, Nancy E Mayo, et al.
Journal of Psychosomatic Research|June 18, 2023
Assessment of differential item functioning of the PHQ-9, HADS-D and PROMIS-depression scales in persons with and without multiple sclerosisRuth Ann Marrie, Lisa M Lix, James M Bolton, et al.
BMC Research Notes|November 28, 2017
Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative dataRuth Ann Marrie, Randy Walld, James M Bolton, et al.
Arthritis Care & Research|June 15, 2019
Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid ArthritisCarol A Hitchon, Lixia Zhang, Christine A Peschken, et al.
Inflammatory Bowel Diseases|September 3, 2024
Psychiatric Comorbidity Does Not Enhance Prescription Opioid Use in Inflammatory Bowel Disease as It Does in the General PopulationCharles N Bernstein, John D Fisk, Randy Walld, et al.
Pageof 40